![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kenvue Inc | NYSE:KVUE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.40 | 2.19% | 18.65 | 18.785 | 18.31 | 18.37 | 7,072,738 | 19:38:29 |
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced a 2.5% increase in the Company’s quarterly dividend as its Board of Directors declared a $0.205 per share dividend on Kenvue common stock payable in the third quarter of 2024. This is a testament to the Company’s commitment to return cash to shareholders as part of its capital allocation strategy designed to enable sustainable growth and optimize total shareholder return. The third quarter dividend is payable on August 28, 2024, to shareholders of record as of the close of business on August 14, 2024.
About Kenvue
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725055250/en/
Investor Relations: Jim Giannakouros, CFA Kenvue_IR@Kenvue.com
Media Relations: Melissa Witt media@kenvue.com
1 Year Kenvue Chart |
1 Month Kenvue Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions